Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer. We are focused on treating one of the most aggressive types of breast cancer, Triple Negative Breast Cancer (TNBC), which currently does not have any approved targeted treatments.
Our innovative treatment potently inhibits cancer cells and is less toxic than the current standard of care.
Our patented cancer compounds position us in the lead to fast track our product to market as it fills an unmet medical need as an effective, safer treatment for a serious medical condition. Our cancer therapy will potentially save lives and improve the lives of cancer patients. Please visit our website at www.phoenixmd.ca for more information.
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
